FIELD: chemistry; pharmaceutics.
SUBSTANCE: invention relates to chemistry and pharmaceutics, namely to a compound of formula (I), having antimycotic activity, and to a pharmaceutical composition based thereon for treating a disease caused by mycobacteria. In general formula (I) R1 is halogen; R2 is H or C1-6 alkyl; Q is a bond or CHR3; R3 is H or C1-6 alkyl; Z is phenyl, optionally substituted with halogen, cyclohexyl or ethynyl; and n is integer from 0 to 2.
EFFECT: use of the invention allows effective treatment of diseases caused by mycobacteria, including tuberculosis.
10 cl, 2 tbl, 3 ex
(I)
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-TUBERCULOSIS AGENTS BEING 3,7-DISUBSTITUTED [1,2,4]TRIAZOLO[1,5-b][1,2,4,5]TETRAZINES | 2022 |
|
RU2802300C1 |
| NEW TETRAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF TUBERCULOSIS | 2018 |
|
RU2800930C2 |
| SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS | 2014 |
|
RU2802185C2 |
| SIMPLE ETHER DERIVATIVE OF NICOTINYL ALCOHOL, A PREPARATION AND A PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2017 |
|
RU2735541C2 |
| IMIDAZOPYRIMIDINES AS EED INHIBITORS AND USE THEREOF | 2020 |
|
RU2836176C2 |
| TRIAZOLOPYRIDINE COMPOUND AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR AND ERYTHROPOIETIN PRODUCTION INDUCER | 2010 |
|
RU2538963C2 |
| AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
| NEW ANTIMICROBIAL COMPOUNDS, THEIR USE FOR TREATMENT OF MAMMALIAN INFECTIONS AND NEW METABOLIC MECHANISM | 2017 |
|
RU2752568C2 |
| COMPOUNDS | 2016 |
|
RU2734877C2 |
| AROMATASE INHIBITORS | 2010 |
|
RU2572244C2 |
